Improvement of cognitive dysfunction with high-dose rivastigmine

Psychosomatics. 2010 Jan-Feb;51(1):89-90. doi: 10.1176/appi.psy.51.1.89.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Cholinesterase Inhibitors / administration & dosage
  • Cholinesterase Inhibitors / therapeutic use*
  • Cognition Disorders / diagnosis
  • Cognition Disorders / drug therapy*
  • Diagnostic and Statistical Manual of Mental Disorders
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Phenylcarbamates / administration & dosage
  • Phenylcarbamates / therapeutic use*
  • Rivastigmine
  • Severity of Illness Index

Substances

  • Cholinesterase Inhibitors
  • Phenylcarbamates
  • Rivastigmine